Pennsylvania Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Buy
1,945
+110
+6% +$12.9K 0.06% 110
2026
Q1
$221K Buy
+1,835
New +$212K 0.06% 109
2025
Q3
Sell
-3,555
Closed -$281K 112
2025
Q2
$281K Sell
3,555
-805
-18% -$64K 0.09% 90
2025
Q1
$391K Sell
4,360
-823
-16% -$76.8K 0.14% 73
2024
Q4
$516K Sell
5,183
-582
-10% -$60K 0.18% 64
2024
Q3
$655K Buy
5,765
+1,722
+43% +$205K 0.24% 53
2024
Q2
$501K Buy
4,043
+475
+13% +$61.2K 0.19% 55
2024
Q1
$471K Buy
3,568
+404
+13% +$49.8K 0.19% 58
2023
Q4
$345K Sell
3,164
-1,123
-26% -$117K 0.14% 72
2023
Q3
$441K Buy
4,287
+34
+0.8% +$3.67K 0.18% 58
2023
Q2
$491K Buy
4,253
+196
+5% +$22.3K 0.21% 53
2023
Q1
$432K Hold
4,057
0.21% 57
2022
Q4
$451K Sell
4,057
-893
-18% -$91.3K 0.24% 61
2022
Q3
$426K Hold
4,950
0.24% 53
2022
Q2
$451K Sell
4,950
-101
-2% -$8.95K 0.24% 50
2022
Q1
$414K Hold
5,051
0.18% 56
2021
Q4
$387K Sell
5,051
-749
-13% -$59.7K 0.13% 76
2021
Q3
$471K Sell
5,800
-341
-6% -$25.9K 0.21% 57
2021
Q2
$479K Sell
6,141
-367
-6% -$27.3K 0.24% 46
2021
Q1
$479K Hold
6,508
0.28% 46
2020
Q4
$511K Sell
6,508
-1,356
-17% -$104K 0.33% 41
2020
Q3
$610K Buy
7,864
+4,838
+160% +$379K 0.48% 31
2020
Q2
$223K Sell
3,026
-4,739
-61% -$357K 0.12% 102
2020
Q1
$565K Hold
7,765
0.73% 22
2019
Q4
$674K Buy
+7,765
New +$638K 0.64% 30

Other funds holding MRK

Pennsylvania Capital Management's MRK Position: Q2 2026 in Review

Pennsylvania Capital Management increased its Merck (MRK) stake by 6% in Q2 2026, buying an estimated $12.9K and bringing the position to 1,945 shares worth $250K. The position accounts for 0.06% of the portfolio, ranked #110.

Pennsylvania Capital Management first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. The position peaked at $674K in Q4 2019. 1,562 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pennsylvania Capital Management held 1,945 shares of Merck worth $250K as of Q2 2026.
  • Pennsylvania Capital Management bought 110 Merck shares in Q2 2026, an estimated $12.9K.
  • Merck made up 0.06% of Pennsylvania Capital Management's portfolio in Q2 2026, its #110 holding.
  • Pennsylvania Capital Management first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
  • Pennsylvania Capital Management's Merck position peaked at $674K in Q4 2019.
  • 1,562 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pennsylvania Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.